← Open Payments lookup

EMMA ELLMAN-GROVES: Open Payments

NPI 1457815771 · NEWARK, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,124 in 57 payments from 12 companies in 2025. Trend: 2023 $849 · 2024 $1,589 · 2025 $1,124

Food & beverage: $1,124
CompanyPaymentsAmount
ABBVIE INC.15$221
Janssen Biotech, Inc.9$182
Salix Pharmaceuticals, a division of Bausch Health US, LLC7$161
Ardelyx, Inc.8$145
GENZYME CORPORATION5$117
Regeneron Healthcare Solutions, Inc.3$85
Takeda Pharmaceuticals U.S.A., Inc.3$71
PFIZER INC.3$46
Exact Sciences Corporation1$34
Aimmune Therapeutics, Inc.1$25

Products named: DUPIXENT, TREMFYA, IBSRELA, RINVOQ, XIFAXAN, RELISTOR, LINZESS, SKYRIZI.

Industry payments across DE — which companies pay providers there.